These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10367556)

  • 1. Rated well-being in relation to plasma concentrations of l- and d-methadone in satisfied and dissatisfied patients on methadone maintenance treatment.
    Hiltunen AJ; Beck O; Hjemdahl P; Liljeberg P; Almström U; Brodin K; von Wachenfeldt J; Borg S
    Psychopharmacology (Berl); 1999 Apr; 143(4):385-93. PubMed ID: 10367556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based pharmacokinetic approach for methadone monitoring of opiate addicts: potential clinical utility.
    Wolff K; Rostami-Hodjegan A; Hay AW; Raistrick D; Tucker G
    Addiction; 2000 Dec; 95(12):1771-83. PubMed ID: 11177493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subjective and objective symptoms in relation to plasma methadone concentration in methadone patients.
    Hiltunen AJ; Lafolie P; Martel J; Ottosson EC; Boreus LO; Beck O; Borg S; Hjemdahl P
    Psychopharmacology (Berl); 1995 Mar; 118(2):122-6. PubMed ID: 7617797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.
    Pérez de los Cobos J; Siñol N; Trujols J; del Río E; Bañuls E; Luquero E; Menoyo A; Queraltó JM; Baiget M; Alvarez E
    Drug Alcohol Depend; 2007 Jul; 89(2-3):190-4. PubMed ID: 17234366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of plasma and urine methadone concentrations to optimize treatment in maintenance clinics: I. Measurement techniques for a clinical setting.
    Kell MJ
    J Addict Dis; 1994; 13(1):5-26. PubMed ID: 8018740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can Saliva and Plasma Methadone Concentrations Be Used for Enantioselective Pharmacokinetic and Pharmacodynamic Studies in Patients With Advanced Cancer?
    George R; Haywood A; Good P; Hennig S; Khan S; Norris R; Hardy J
    Clin Ther; 2017 Sep; 39(9):1840-1848. PubMed ID: 28827023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.
    Torrens M; Castillo C; San L; del Moral E; González ML; de la Torre R
    Drug Alcohol Depend; 1998 Nov; 52(3):193-200. PubMed ID: 9839145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-Methadone and D,L-methadone in methadone maintenance treatment: a comparison of therapeutic effectiveness and plasma concentrations.
    de Vos JW; Ufkes JG; Kaplan CD; Tursch M; Krause JK; van Wilgenburg H; Woodcock BG; Staib AH
    Eur Addict Res; 1998 Sep; 4(3):134-41. PubMed ID: 9742275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered methadone pharmacokinetics in pregnancy: implications for dosing.
    Swift RM; Dudley M; DePetrillo P; Camara P; Griffiths W
    J Subst Abuse; 1989; 1(4):453-60. PubMed ID: 2485290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone dose, plasma level, and cross-tolerance to heroin in man.
    Volavka J; Verebey K; Resnick R; Mulé S
    J Nerv Ment Dis; 1978 Feb; 166(2):104-9. PubMed ID: 627883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inadequate plasma concentrations in some high-dose methadone maintenance patients.
    Tennant FS
    Am J Psychiatry; 1987 Oct; 144(10):1349-50. PubMed ID: 3661772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between plasma concentrations of the l-enantiomer of methadone and response to methadone maintenance treatment.
    Meini M; Moncini M; Daini L; Giarratana T; Scaramelli D; Chericoni S; Stefanelli F; Rucci P
    Eur J Pharmacol; 2015 Aug; 760():1-6. PubMed ID: 25891369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of serum methadone levels in patients receiving methadone maintenance.
    Bell J; Seres V; Bowron P; Lewis J; Batey R
    Clin Pharmacol Ther; 1988 Jun; 43(6):623-9. PubMed ID: 3378383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perspectives on methadone maintenance treatment in the Valencia Region: dose adjustment, participation in dosage regulation, and satisfaction with treatment.
    Pérez de Los Cobos J; Trujols J; Valderrama JC; Valero S; Puig T
    Drug Alcohol Depend; 2005 Sep; 79(3):405-12. PubMed ID: 15869846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine abuse in methadone maintenance patients is associated with low serum methadone concentrations.
    Tennant F; Shannon J
    J Addict Dis; 1995; 14(1):67-74. PubMed ID: 7632748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels and symptom complaints in patients maintained on daily dosage of methadone hydrochloride.
    Horns WH; Rado M; Goldstein A
    Clin Pharmacol Ther; 1975 Jun; 17(6):636-49. PubMed ID: 1139855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacokinetics of methadone in healthy subjects and opiate users.
    Wolff K; Rostami-Hodjegan A; Shires S; Hay AW; Feely M; Calvert R; Raistrick D; Tucker GT
    Br J Clin Pharmacol; 1997 Oct; 44(4):325-34. PubMed ID: 9354306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Abuse of alcohol and benzodiazepine during substitution therapy in heroin addicts: a review of the literature].
    Laqueille X; Launay C; Dervaux A; Kanit M
    Encephale; 2009 Jun; 35(3):220-5. PubMed ID: 19540407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of methadone in maintenance clients who persist in illicit drug use.
    Bell J; Bowron P; Lewis J; Batey R
    Br J Addict; 1990 Dec; 85(12):1599-602. PubMed ID: 1981155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.